reduce mortality in sheep

Cardiovascular prevention reduction of cardiovascular morbidity and mortality in patients with

Reduction in risk of cardiovascular morbidity and mortality in hypertensive patients with left

Reduction of cardiovascular morbidity and mortality (or risk of stroke) in hypertensive patients with left ventricular hypertrophy.

Overall study mortality Mortality during study therapy Mortality attributed to Candida infection

The long term efficacy of antihypertensive therapy with losartan in childhood to reduce cardiovascular morbidity and mortality has also not been established.

Therefore, the CHMP considered that the benefit risk for the indication Reduction in risk of cardiovascular morbidity and mortality (or risk of stroke_) in hypertensive patients with left ventricular hypertrophy is negative and this indication is not acceptable for the FDC.

Mortality

a reduction of clinical signs during the symptomatic phase (4 months)

Acute Mortality

Secondary prevention after acute myocardial infarction reduction of mortality from the acute phase of myocardial infarction in patients with clinical signs of heart failure when started 48 hours following acute myocardial infarction.

Secondary prevention after acute myocardial infarction reduction of mortality from the acute phase

Nor does it have the legal right to do so in the poorest of countries in the world, but this does not deny women the highest level of medical care to prevent maternal mortality and morbidity.

There was no difference in mortality.

METHOD AND ROUTE(S) OF ADMINISTRATION

status) and mortality

Prevalence estimates of problem drug use

MBA WHO global network meeting

Reduction of mortality and virus excretion after challenge.

25 (p 0.0001)

echocardiography data, where available) and mortality

CPMP 6214 03 results showed

Drugrelated deaths and mortality among drug users

Demand reduction

Increase the quality of initial teacher training, the quality of the recruitment procedures and the attractiveness of jobs in the education sector, including through the level of financial reward

The reduction in PTH levels also leads to a decrease in blood calcium levels.

The results a 43 reduction in mortality and a 39 decrease in hospital visits among patients who received BiDil were so striking that the study was concluded early.

No increase in mortality from heart failure was observed.

The effect of sildenafil on mortality is unknown.

No increase in mortality from heart failure was observed.

13 One retrospective European study evaluating the use of G CSF after allogeneic bone marrow transplantation in patients with acute leukaemias suggested an increase in the risk of GvHD, treatment related mortality (TRM) and mortality when G CSF was administered.

29 One retrospective European study evaluating the use of G CSF after allogeneic bone marrow transplantation in patients with acute leukaemias suggested an increase in the risk of GvHD, treatment related mortality (TRM) and mortality when G CSF was administered.

13 related mortality (TRM) and mortality when G CSF was administered.

29 related mortality (TRM) and mortality when G CSF was administered.

Mortality among these patients was nil.

Early symptoms (symptomatic hyperlactataemia) include benign digestive symptoms (nausea, vomiting and abdominal pain), non specific malaise, loss of appetite, weight loss, respiratory symptoms (rapid and or deep breathing) or neurological symptoms (including motor weakness).

Efficacy has been evaluated on the basis of preliminary results in chickens and ringed teals. In chickens, reduction of clinical signs, mortality, excretion and transmission of virus after challenge were shown by two weeks after a single dose vaccination. In ducks, reduction of excretion and transmission of virus after challenge were shown by two weeks after a single dose vaccination.

Lenz decisions taken on these matters.

Gradual reduction of Registration Tax

Faster reductions in customs duties

Article 25

Risk reductions for all cause mortality (8 p 0.128) and cardiovascular mortality (10 p 0.073) were observed.

The LIFE study has been assessed in the past and this has led to the registration of the more extensive indication, i. e. the reduction of the cardiovascular morbidity and mortality (as measured by the combined incidence of CV death, stroke

No increase in mortality from heart failure was observed.

However, angiotensin converting enzyme inhibitors, as a class, have been shown to induce adverse effects on late foetal development, resulting in foetal death and congenital effects in rodents and rabbits renal lesions and an increase in peri and postnatal mortality have been observed.